Lightheadedness at higher per-dose amounts
A vial at day 21 has not suddenly become useless
It is not represented as an FDA-approved drug, dietary supplement, weight-management product, metabolic treatment, anti-aging product, or NAD + therapy
Rev1 contributes to proper mitochondrial function via the PARP-NAD(+)-SIRT1-PGC1 axis
While NAD+ is considered safe at a wide range of doses, higher doses may increase the risk of side effects such as fatigue, nausea, or flu-like symptoms
Similar clinical symptoms are found in individuals with hereditary IF deficiency (also called congenital pernicious anemia) in whom the lack of IF results in the defective absorption of vitamin B 12